Ruggiero Norfo
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model.
Journal: Blood cancer journal
Published: September 05, 2025
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis.
Journal: Journal of cellular and molecular medicine
Published: January 30, 2025
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.
Journal: Science translational medicine
Published: October 09, 2024
Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts.
Journal: American journal of hematology
Published: March 28, 2024
Ancient genomic linkage of α-globin and Nprl3 couples metabolism with erythropoiesis.
Journal: Nature communications
Published: January 29, 2024
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms.
Journal: Leukemia
Published: January 22, 2024
Ancient genomic linkage couples metabolism with erythroid development.
Journal: bioRxiv : the preprint server for biology
Published: October 09, 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.
Journal: Nature genetics
Published: February 18, 2022
Last Updated: 09/26/2026